Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

598 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Notice to Attend The Annual General Meeting in Ranplan Group AB
AQ
Certain A Shares of Suzhou Iron Technology CO.,LTD. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Certain A Shares of Jiangsu Leadmicro Nano-Equipment Technology Ltd are subject to a Lock-Up Agreement Ending on 20-DEC-2023.
CI
Guangxi Guangtou Industrial Chain Service Group Co., Ltd. completed the acquisition of 2% stake in Guangxi Yongsheng Petrochemical Co., Ltd. from Guangxi Energy Co., Ltd..
CI
Certain A Shares of 3Peak Incorporated are subject to a Lock-Up Agreement Ending on 21-SEP-2023.
CI
Guangxi Guangtou Industrial Chain Service Group Co., Ltd. agreed to acquire 2% stake in Guangxi Yongsheng Petrochemical Co., Ltd. from Guangxi Energy Co., Ltd. for CNY 11 million.
CI
ZheJiang Haers Vacuum Containers Co.,Ltd. Approves Executive Appointments
CI
GBT Technologies : A qualitative study that explores the implementation of artificial intelligence in integrated circuit design - Form 8-K
PU
Chijet Motor Company, Inc. Approves Board Elections
CI
Chijet Motor Company Holds First Board Meeting After Completing its Business Combination
GL
Zhongguancun Science-Tech Leasing Co., Ltd. Announces Board Appointments
CI
Certain A Shares of Kaili Catalyst & New Materials Co.,Ltd. are subject to a Lock-Up Agreement Ending on 9-JUN-2023.
CI
HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting
GL
HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting
AQ
AirAsia : signs Cooperation Framework with Fuzhou City Government to turn Fuzhou Airport as a gateway hub to Southeast Asia
PU
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes
CI
Chengdu Fangda Tantan Composite Material Co., Ltd. announced that it expects to receive CNY 161.029823 million in funding from Shanghai Fangda Investment Management Co., Ltd., FangDa Carbon New Material Co.,Ltd and other investors
CI
Alibaba Group Announces March Quarter and Full Fiscal Year 2023 Results
BU
Certain A Shares of Hebei Huatong Wires and Cables Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 11-MAY-2023.
CI
The China NMPA Approves TYVYT® (sintilimab injection) in Combination with Bevacizumab and Chemotherapy in Patients with EGFR-mutated Non-squamous NSCLC who Progressed after EGFR-TKI Therapy
PR
Huasu Holdings Co.,Ltd Announces Management Changes
CI
The Artprice100© index of Blue-chip artists up 3% over 2022 Vs S&P 500 -19%
AQ
Artmarket.com : Artmarket.com: the Artprice100(C) index of Blue-chip artists up 3% over 2022 Vs SP 500 -19%
AT
Fosun International : Foundation and the National Medical Center for Infectious Diseases Formed a Partnership to Help Achieve the Goal of Global Tuberculosis Elimination by 2035
PU
Certain A Shares of 3Peak Incorporated are subject to a Lock-Up Agreement Ending on 21-SEP-2022.
CI
Jiangsu Jingxue Insulation Technology Co.,Ltd. Announces Executive Changes
CI
Transcript : China Mengniu Dairy Company Limited, Yashili International Holdings Ltd, H1 2022 Earnings Call, Aug 25, 2022
Transcript : Kanzhun Limited, Q2 2022 Earnings Call, Aug 23, 2022
Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy
PR
Yieh Phui : announces that the board of directors has approved the lifting of the non-compete clause for the management
PU
XiaMen HongXin Electron-tech Group Co.,Ltd completed the acquisition of Suzhou Smartron Technology Corporation Limited from Wu Shaofeng, Zhu Xiaoyan, Suzhou Huayang Tongchuang Investment Center (Limited Partnership) and Yan Yonghong.
CI
China NMPA Approves Tislelizumab for Recurrent or Metastatic Nasopharyngeal Cancer
BU
ScinoPharm Taiwan : Announce the Company's 2022 Shareholders' Meeting approved to release the Directors and their representatives from non-competition restrictions
PU
TTET Union : 2022 Reqular Shareholders’ Meeting releases the company's directors from non-competition restrictions.
PU
Certain A Shares of Hebei Huatong Wires and Cables Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 11-MAY-2022.
CI
Certain A Shares of Suzhou Iron Technology CO.,LTD. are subject to a Lock-Up Agreement Ending on 29-MAR-2022.
CI
Huobi Technology Holdings Limited Announces Executive Changes
CI
BeiGene : Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021 - Form 8-K
PU
BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021
BU
Metallurgical of China : MCC commenced its MASTEEL New Special Steel Project officially
PU
Certain A Shares of 3Peak Incorporated are subject to a Lock-Up Agreement Ending on 21-SEP-2021.
CI
Sinopharm : 2021 Interim Report
PU
Transcript : China Mengniu Dairy Company Limited, Yashili International Holdings Ltd, H1 2021 Earnings Call, Aug 26, 2021
BeiGene : Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer (Form 8-K)
PU
BeiGene : Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer
BU
Ahoku Electronic Company Announces Establishment of the First Term of Audit Committee
CI
President Chain Store : Announcement of the 2021 Shareholder's Meeting to permit the directors to engage in competitive conduct
PU
XiaMen HongXin Electron-tech Group Co.,Ltd agreed to acquire Suzhou Smartron Technology Corporation Limited from Wu Shaofeng, Zhu Xiaoyan, Suzhou Huayang Tongchuang Investment Center (Limited Partnership) and Yan Yonghong for CNY 480 million.
CI
BeiGene : Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
AQ
BeiGene : Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
BU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Wen Wu Zhang
  4. News